HC Wainwright & Co. Downgrades Vyant Bio to Neutral
HC Wainwright & Co. analyst Edward White downgrades Vyant Bio (NASDAQ:VYNT) from Buy to Neutral.
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Yield10 Bioscience (NASDAQ:YTEN) shares increased by 35.2% to $2.84 during Thursday’s regular session. Trading volume for Yield10…
Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket
Gainers
OncoCyte Corporation (NASDAQ: OCX) rose 89.2% to $0.70 in pre-market trading. Oncocyte, last month, announced an over 40% reduction of its workforce to realign the team towards key products that address larger markets.
Walgreens, Constellation Brands And 3 Stocks To Watch Heading Into Thursday
With US stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows:
Why Vyant Bio Shares Are Soaring After Hours
Vyant Bio Inc (NASDAQ: VYNT) shares are trading higher Wednesday after the company engaged LifeSci Capital as an advisor to
Vyant Bio Engages LifeSci Capital To Explore Strategic Alternatives
Vyant Bio, Inc. ("Vyant Bio" or "Company") (NASDAQ:VYNT) is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. The
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 325 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 160 companies set new 52-week lows.
